FDA Inspection 828132 — Actelion Pharmaceuticals Ltd.
The FDA completed an inspection of Actelion Pharmaceuticals Ltd. on April 19, 2013 in Allschwil. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 19, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Allschwil (Switzerland)
Additional Details
Sponsor, Contract Research Organization